<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39340095</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>18</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>Effectiveness of COVID-19 Vaccines in People with Severe Mental Illness: A Systematic Review and Meta-Analysis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1064</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines12091064</ELocationID><Abstract><AbstractText>Prior to the introduction of COVID-19 vaccines, patients with severe mental illness (SMI) were at greater risk of COVID-19-related outcomes than the general population. It is not yet clear whether COVID-19 vaccines have reduced the risk gap. We systematically searched nine international databases and three Chinese databases to identify relevant studies from December 2020 to December 2023 to compare the risk of COVID-19-related outcomes for SMI patients to those without SMI after vaccination. Random effects meta-analysis was performed to estimate the pooled odds ratio (OR) with 95% confidence intervals (CI). Subgroup analysis, sensitivity analysis, and publication bias analysis were conducted with R software 4.3.0. A total of 11 observational studies were included. Compared with controls, SMI patients were associated with a slightly increased risk of infection (pooled OR = 1.10, 95% CI, 1.03-1.17, <i>I</i><sup>2</sup> = 43.4%), while showing a 2-fold higher risk of hospitalization (pooled OR = 2.66, 95% CI, 1.13-6.22, <i>I</i><sup>2</sup> = 99.6%), even after both groups have received COVID-19 vaccines. Limited evidence suggests a higher mortality risk among SMI patients compared to controls post vaccination, but the findings did not reach statistical significance. SMI patients remain at increased risk compared to their peers in COVID-19-related outcomes even after vaccination. Vaccination appears an effective approach to prevent severe COVID-19 illness in SMI patients, and actions should be taken by healthcare providers to improve vaccination coverage in these vulnerable groups.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dang</LastName><ForeName>Wen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Unit of Psychiatry, Department of Public Health and Medicinal Administration, Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macao SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Long</LastName><ForeName>Iman</ForeName><Initials>I</Initials><Identifier Source="ORCID">0009-0008-2656-7837</Identifier><AffiliationInfo><Affiliation>Unit of Psychiatry, Department of Public Health and Medicinal Administration, Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macao SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Yiwei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Unit of Psychiatry, Department of Public Health and Medicinal Administration, Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macao SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiang</LastName><ForeName>Yu-Tao</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Unit of Psychiatry, Department of Public Health and Medicinal Administration, Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macao SAR, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Cognitive and Brain Sciences, University of Macau, Macao SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Robert David</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Unit of Psychiatry, Department of Public Health and Medicinal Administration, Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macao SAR, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>No</GrantID><Agency>Internal grant of the Faculty of Health Sciences, University of Macau</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 vaccines</Keyword><Keyword MajorTopicYN="N">bipolar disorder</Keyword><Keyword MajorTopicYN="N">major depressive disorder</Keyword><Keyword MajorTopicYN="N">schizophrenia</Keyword><Keyword MajorTopicYN="N">severe mental illness</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39340095</ArticleId><ArticleId IdType="pmc">PMC11436207</ArticleId><ArticleId IdType="doi">10.3390/vaccines12091064</ArticleId><ArticleId IdType="pii">vaccines12091064</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cucciare M.A. 6—SUPPORT GROUPS. In: O’Donohue W.T., Cummings N.A., editors. Evidence-Based Adjunctive Treatments. Academic Press; San Diego, CA, USA: 2008. pp. 123–140.</Citation></Reference><Reference><Citation>Hassan L., Peek N., Lovell K., Carvalho A.A.-O., Solmi M.A.-O., Stubbs B., Firth J.A.-O. Disparities in COVID-19 infection, hospitalisation and death in people with schizophrenia, bipolar disorder, and major depressive disorder: A cohort study of the UK Biobank. Mol. Psychiatry. 2022;27:1248–1255. doi: 10.1038/s41380-021-01344-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-021-01344-2</ArticleId><ArticleId IdType="pmc">PMC9054655</ArticleId><ArticleId IdType="pubmed">34873324</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronaldson A., Elton L., Jayakumar S., Jieman A., Halvorsrud K., Bhui K. Severe mental illness and health service utilisation for nonpsychiatric medical disorders: A systematic review and meta-analysis. PLoS Med. 2020;17:e1003284. doi: 10.1371/journal.pmed.1003284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003284</ArticleId><ArticleId IdType="pmc">PMC7489517</ArticleId><ArticleId IdType="pubmed">32925912</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan L., Sawyer C., Peek N., Lovell K., Carvalho A.F., Solmi M., Tilston G., Sperrin M., Firth J. COVID-19 vaccination uptake in people with severe mental illness: A UK-based cohort study. World Psychiatry. 2022;21:153–154. doi: 10.1002/wps.20945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wps.20945</ArticleId><ArticleId IdType="pmc">PMC8751570</ArticleId><ArticleId IdType="pubmed">35015350</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan L., Sawyer C., Peek N., Lovell K., Carvalho A.F., Solmi M., Tilston G., Sperrin M., Firth J. Heightened COVID-19 Mortality in People with Severe Mental Illness Persists After Vaccination: A Cohort Study of Greater Manchester Residents. Schizophr. Bull. 2022;49:275–284. doi: 10.1093/schbul/sbac118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/schbul/sbac118</ArticleId><ArticleId IdType="pmc">PMC9452124</ArticleId><ArticleId IdType="pubmed">36029257</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamada K., Fan X. The impact of COVID-19 on individuals living with serious mental illness. Schizophr. Res. 2020;222:3–5. doi: 10.1016/j.schres.2020.05.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.schres.2020.05.054</ArticleId><ArticleId IdType="pmc">PMC7250778</ArticleId><ArticleId IdType="pubmed">32473931</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute of Mental Health  Mental Illness.  [(accessed on 18 May 2023)];2021  Available online:  https://www.nimh.nih.gov/health/statistics/mental-illness.</Citation></Reference><Reference><Citation>Australian Institute of Health and Welfare  Prevalence and Impact of Mental Illness.  [(accessed on 18 March 2024)];2023  Available online:  https://www.aihw.gov.au/getmedia/622ae08e-1c2f-45df-9682-10a3e0c41fe1/prevalence-and-impact-of-mental-illness-2022.pdf.aspx.</Citation></Reference><Reference><Citation>NHS Digital  Quality and Outcomes Framework, 2022–2023. 2023.  [(accessed on 18 March 2024)].  Available online:  https://digital.nhs.uk/data-and-information/publications/statistical/quality-and-outcomes-framework-achievement-prevalence-and-exceptions-data/2022-23.</Citation></Reference><Reference><Citation>GBD 2019 Mental Disorders Collaborators Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022;9:137–150. doi: 10.1016/S2215-0366(21)00395-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00395-3</ArticleId><ArticleId IdType="pmc">PMC8776563</ArticleId><ArticleId IdType="pubmed">35026139</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker E.R., McGee R.E., Druss B.G. Mortality in mental disorders and global disease burden implications: A systematic review and meta-analysis. JAMA Psychiatry. 2015;72:334–341. doi: 10.1001/jamapsychiatry.2014.2502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2014.2502</ArticleId><ArticleId IdType="pmc">PMC4461039</ArticleId><ArticleId IdType="pubmed">25671328</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjorthøj C., Stürup A.E., McGrath J.J., Nordentoft M. Years of potential life lost and life expectancy in schizophrenia: A systematic review and meta-analysis. Lancet Psychiatry. 2017;4:295–301. doi: 10.1016/S2215-0366(17)30078-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(17)30078-0</ArticleId><ArticleId IdType="pubmed">28237639</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan J.K.N., Tong C.H.Y., Wong C.S.M., Chen E.Y.H., Chang W.C. Life expectancy and years of potential life lost in bipolar disorder: Systematic review and meta-analysis. Br. J. Psychiatry. 2022;221:567–576. doi: 10.1192/bjp.2022.19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.2022.19</ArticleId><ArticleId IdType="pubmed">35184778</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiorillo A., Sartorius N. Mortality gap and physical comorbidity of people with severe mental disorders: The public health scandal. Ann. Gen. Psychiatry. 2021;20:52. doi: 10.1186/s12991-021-00374-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12991-021-00374-y</ArticleId><ArticleId IdType="pmc">PMC8670051</ArticleId><ArticleId IdType="pubmed">34903254</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham C., Peters K., Mannix J. Physical Health Inequities in People with Severe Mental Illness: Identifying Initiatives for Practice Change. Issues Ment. Health Nurs. 2013;34:855–862. doi: 10.3109/01612840.2013.832826.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/01612840.2013.832826</ArticleId><ArticleId IdType="pubmed">24274241</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H., Chen W., Hu Y., Chen Y., Zeng Y., Sun Y., Ying Z., He J., Qu Y., Lu D., et al. Pre-pandemic psychiatric disorders and risk of COVID-19: A UK Biobank cohort analysis. Lancet Healthy Longev. 2020;1:e69–e79. doi: 10.1016/S2666-7568(20)30013-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-7568(20)30013-1</ArticleId><ArticleId IdType="pmc">PMC7832159</ArticleId><ArticleId IdType="pubmed">33521769</ArticleId></ArticleIdList></Reference><Reference><Citation>Toubasi A.A., AbuAnzeh R.B., Tawileh H.B.A., Aldebei R.H., Alryalat S.A.S. A meta-analysis: The mortality and severity of COVID-19 among patients with mental disorders. Psychiatry Res. 2021;299:113856. doi: 10.1016/j.psychres.2021.113856.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2021.113856</ArticleId><ArticleId IdType="pmc">PMC7927594</ArticleId><ArticleId IdType="pubmed">33740483</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Xu R., Volkow N.D. Increased risk of COVID-19 infection and mortality in people with mental disorders: Analysis from electronic health records in the United States. World Psychiatry. 2021;20:124–130. doi: 10.1002/wps.20806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wps.20806</ArticleId><ArticleId IdType="pmc">PMC7675495</ArticleId><ArticleId IdType="pubmed">33026219</ArticleId></ArticleIdList></Reference><Reference><Citation>De Hert M., Mazereel V., Stroobants M., De Picker L., Van Assche K., Detraux J. COVID-19-Related Mortality Risk in People with Severe Mental Illness: A Systematic and Critical Review. Front. Psychiatry. 2021;12:798554. doi: 10.3389/fpsyt.2021.798554.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.798554</ArticleId><ArticleId IdType="pmc">PMC8793909</ArticleId><ArticleId IdType="pubmed">35095612</ArticleId></ArticleIdList></Reference><Reference><Citation>Fond G., Nemani K., Etchecopar-Etchart D., Loundou A., Goff D.C., Lee S.W., Lancon C., Auquier P., Baumstarck K., Llorca P.M., et al. Association Between Mental Health Disorders and Mortality Among Patients With COVID-19 in 7 Countries: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2021;78:1208–1217. doi: 10.1001/jamapsychiatry.2021.2274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2021.2274</ArticleId><ArticleId IdType="pmc">PMC8317055</ArticleId><ArticleId IdType="pubmed">34313711</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokuda Y., Barnett P.B., Sanji S., Takaizumi Y., Tomono M., Tokuda H., Taniguchi K., Shibuya K. Serious mental illness and in-hospital mortality among hospitalized patients with acute COVID-19: A large-database analysis in Japan. Gen. Hosp. Psychiatry. 2023;82:1–6. doi: 10.1016/j.genhosppsych.2023.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genhosppsych.2023.01.014</ArticleId><ArticleId IdType="pmc">PMC9894824</ArticleId><ArticleId IdType="pubmed">36868102</ArticleId></ArticleIdList></Reference><Reference><Citation>Zisis S.N., Durieux J.C., Mouchati C., Perez J.A., McComsey G.A. The Protective Effect of Coronavirus Disease 2019 (COVID-19) Vaccination on Postacute Sequelae of COVID-19: A Multicenter Study from a Large National Health Research Network. Open Forum. Infect. Dis. 2022;9:ofac228. doi: 10.1093/ofid/ofac228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac228</ArticleId><ArticleId IdType="pmc">PMC9129153</ArticleId><ArticleId IdType="pubmed">35818362</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Qin C., Liu M., Liu J. Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: A systematic review and meta-analysis. Infect. Dis. Poverty. 2021;10:132. doi: 10.1186/s40249-021-00915-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-021-00915-3</ArticleId><ArticleId IdType="pmc">PMC8590867</ArticleId><ArticleId IdType="pubmed">34776011</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearson C.A.B., Bozzani F., Procter S.R., Davies N.G., Huda M., Jensen H.T., Keogh-Brown M., Khalid M., Sweeney S., Torres-Rueda S., et al. COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness. PLoS Med. 2021;18:e1003815. doi: 10.1371/journal.pmed.1003815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003815</ArticleId><ArticleId IdType="pmc">PMC8523052</ArticleId><ArticleId IdType="pubmed">34606520</ArticleId></ArticleIdList></Reference><Reference><Citation>Utami A.M., Rendrayani F., Khoiry Q.A., Alfiani F., Kusuma A.S.W., Suwantika A.A. Cost-Effectiveness Analysis of COVID-19 Vaccination in Low- and Middle-Income Countries. J. Multidiscip. Heal. 2022;15:2067–2076. doi: 10.2147/JMDH.S372000.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JMDH.S372000</ArticleId><ArticleId IdType="pmc">PMC9482370</ArticleId><ArticleId IdType="pubmed">36124175</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmani K., Shavaleh R., Forouhi M., Disfani H.F., Kamandi M., Oskooi R.K., Foogerdi M., Soltani M., Rahchamani M., Mohaddespour M., et al. The effectiveness of COVID-19 vaccines in reducing the incidence, hospitalization, and mortality from COVID-19: A systematic review and meta-analysis. Front. Public Health. 2022;10:873596. doi: 10.3389/fpubh.2022.873596.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.873596</ArticleId><ArticleId IdType="pmc">PMC9459165</ArticleId><ArticleId IdType="pubmed">36091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Marc D.H., Victor M., Johan D., Kristof V.A. Prioritizing COVID-19 vaccination for people with severe mental illness. World Psychiatry. 2020;20:54–55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7801845</ArticleId><ArticleId IdType="pubmed">33131217</ArticleId></ArticleIdList></Reference><Reference><Citation>De Picker L.J., Dias M.C., Benros M.E., Vai B., Branchi I., Benedetti F., Borsini A., Leza J.C., Kärkkäinen H., Männikkö M., et al. Severe mental illness and European COVID-19 vaccination strategies. Lancet Psychiatry. 2021;8:356–359. doi: 10.1016/S2215-0366(21)00046-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00046-8</ArticleId><ArticleId IdType="pmc">PMC7906735</ArticleId><ArticleId IdType="pubmed">33609450</ArticleId></ArticleIdList></Reference><Reference><Citation>Victor M., Kristof V.A., Johan D., Marc D.H. COVID-19 vaccination for people with severe mental illness: Why, what, and how? Lancet Psychiatry. 2021;8:444–450.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7906686</ArticleId><ArticleId IdType="pubmed">33548184</ArticleId></ArticleIdList></Reference><Reference><Citation>Siva N. Severe mental illness: Reassessing COVID-19 vaccine priorities. Lancet. 2021;397:657. doi: 10.1016/S0140-6736(21)00429-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00429-3</ArticleId><ArticleId IdType="pmc">PMC7906718</ArticleId><ArticleId IdType="pubmed">33610199</ArticleId></ArticleIdList></Reference><Reference><Citation>Varshney P., Mamtani H., Kumar C.N., Chandra P.S. COVID-19 Vaccination for Persons with Severe Mental Illnesses: An Indian Perspective. Indian J. Psychol. Med. 2021;43:436–441. doi: 10.1177/02537176211033933.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/02537176211033933</ArticleId><ArticleId IdType="pmc">PMC8450732</ArticleId><ArticleId IdType="pubmed">34584310</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein C., Nassereldine H., Sorensen R.J.D., Amlag J.O., Bisignano C., Byrne S., Castro E., Coberly K., Collins J.K., Dalos J., et al. Past SARS-CoV-2 infection protection against re-infection: A systematic review and meta-analysis. Lancet. 2023;401:833–842. doi: 10.1016/S0140-6736(22)02465-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)02465-5</ArticleId><ArticleId IdType="pmc">PMC9998097</ArticleId><ArticleId IdType="pubmed">36930674</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickerson F., Yolken R. Response to the COVID-19 Vaccine in Persons with Schizophrenia and Other Serious Mental Illnesses. J. Affect Disord. Rep. 2023;12:100534. doi: 10.1016/j.jadr.2023.100534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jadr.2023.100534</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., Moher D., Becker B.J., Sipe T.A., Thacker S.B. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008–2012. doi: 10.1001/jama.283.15.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.283.15.2008</ArticleId><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., Shamseer L., Tetzlaff J.M., Akl E.A., Brennan S.E., et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen B., Waitzberg R., Israeli A. Israel’s rapid rollout of vaccinations for COVID-19. Isr. J. Health Policy Res. 2021;10:6. doi: 10.1186/s13584-021-00440-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13584-021-00440-6</ArticleId><ArticleId IdType="pmc">PMC7835664</ArticleId><ArticleId IdType="pubmed">33499905</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouzzani M., Hammady H., Fedorowicz Z., Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst. Rev. 2016;5:210. doi: 10.1186/s13643-016-0384-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-016-0384-4</ArticleId><ArticleId IdType="pmc">PMC5139140</ArticleId><ArticleId IdType="pubmed">27919275</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  Coronavirus Disease (COVID-19): Vaccines and Vaccine Safety.  [(accessed on 20 May 2023)].  Available online:  https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-(covid-19)-vaccines?adgroupsurvey=%7Badgroupsurvey%7D&amp;gclid=EAIaIQobChMIl4bD7c_0_wIVa9QWBR3zuwQHEAAYASAAEgJ5J_D_BwE.</Citation></Reference><Reference><Citation>Wells G.A., Shea B., O’Connell D., Peterson J., Welch V., Losos M., Tugwell P. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta-Analyses. Ottawa Hospital Research Institute. 2000.  [(accessed on 20 September 2022)].  Available online:  http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.</Citation></Reference><Reference><Citation>Gierisch J.M., Beadles C., Shapiro A., McDuffie J.R., Cunningham N., Bradford D., Strauss J., Callahan M., Chen M., Hemminger A., et al. Health Disparities in Quality Indicators of Healthcare Among Adults with Mental Illness. Department of Veterans Affairs (US); Washington, DC, USA: 2014.</Citation><ArticleIdList><ArticleId IdType="pubmed">26065051</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team . R: A Language and Environment for Statistical Computing. R Core Team; Vienna, Austria: 2023.</Citation></Reference><Reference><Citation>Nishimi K., Neylan T.C., Bertenthal D., Seal K.H., O’Donovan A. Association of Psychiatric Disorders with Incidence of SARS-CoV-2 Breakthrough Infection Among Vaccinated Adults. JAMA Netw. Open. 2022;5:e227287. doi: 10.1001/jamanetworkopen.2022.7287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.7287</ArticleId><ArticleId IdType="pmc">PMC9011123</ArticleId><ArticleId IdType="pubmed">35420660</ArticleId></ArticleIdList></Reference><Reference><Citation>Piazza M.F., Amicizia D., Marchini F., Astengo M., Grammatico F., Battaglini A., Sticchi C., Paganino C., Lavieri R., Andreoli G.B., et al. Who Is at Higher Risk of SARS-CoV-2 Reinfection? Results from a Northern Region of Italy. Vaccines. 2022;10:1885. doi: 10.3390/vaccines10111885.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10111885</ArticleId><ArticleId IdType="pmc">PMC9692964</ArticleId><ArticleId IdType="pubmed">36366393</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng W.J., Shih H.M., Su K.P., Hsueh P.R. Risk factors for poor COVID-19 outcomes in patients with psychiatric disorders. Brain Behav. Immun. 2023;114:255–261. doi: 10.1016/j.bbi.2023.08.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2023.08.024</ArticleId><ArticleId IdType="pubmed">37648008</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward I., Robertson C., Agrawal U., Patterson L., Bradley D.T., Shi T., de Lusignan S., Hobbs R., Sheikh A., Nafilyan V. Risk of COVID-19 death in adults who received booster COVID-19 vaccinations in England. Nat. Commun. 2024;15:398. doi: 10.1038/s41467-023-44276-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-44276-x</ArticleId><ArticleId IdType="pmc">PMC10791661</ArticleId><ArticleId IdType="pubmed">38228613</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzur Bitan D., Kridin K., Cohen A.D., Weinstein O. COVID-19 hospitalisation, mortality, vaccination, and postvaccination trends among people with schizophrenia in Israel: A longitudinal cohort study. Lancet Psychiatry. 2021;8:901–908. doi: 10.1016/S2215-0366(21)00256-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00256-X</ArticleId><ArticleId IdType="pmc">PMC8342316</ArticleId><ArticleId IdType="pubmed">34364406</ArticleId></ArticleIdList></Reference><Reference><Citation>Semenzato L., Botton J., Drouin J., Baricault B., Bertrand M., Jabagi M.-J., Cuenot F., Vu S.L., Dray-Spira R., Weill A., et al. Characteristics associated with the residual risk of severe COVID-19 after a complete vaccination schedule: A cohort study of 28 million people in France. Lancet Reg. Health Eur. 2022;19:100441. doi: 10.1016/j.lanepe.2022.100441.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2022.100441</ArticleId><ArticleId IdType="pmc">PMC9243470</ArticleId><ArticleId IdType="pubmed">35789881</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrao G., Franchi M., Cereda D., Bortolan F., Leoni O., Borriello C.R., Della Valle P.G., Tirani M., Pavesi G., Barone A., et al. Vulnerability Predictors of Post-Vaccine SARS-CoV-2 Infection and Disease—Empirical Evidence from a Large Population-Based Italian Platform. Vaccines. 2022;10:845. doi: 10.3390/vaccines10060845.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10060845</ArticleId><ArticleId IdType="pmc">PMC9230065</ArticleId><ArticleId IdType="pubmed">35746453</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrao G., Franchi M., Cereda D., Bortolan F., Leoni O., Jara J., Valenti G., Pavesi G. Factors associated with severe or fatal clinical manifestations of SARS-CoV-2 infection after receiving the third dose of vaccine. J. Intern. Med. 2022;292:829–836. doi: 10.1111/joim.13551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13551</ArticleId><ArticleId IdType="pmc">PMC9539163</ArticleId><ArticleId IdType="pubmed">35943414</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J., Tian H., Wang H., Yu H., Liu C., Wang L., Li Q., Fang T., Jia F., Li Y., et al. Higher benefit-risk ratio of COVID-19 vaccination in patients with schizophrenia and major depressive disorder versus patients with bipolar disorder when compared to controls. Am. J. Transl. Res. 2022;14:5719–5729.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9452368</ArticleId><ArticleId IdType="pubmed">36105010</ArticleId></ArticleIdList></Reference><Reference><Citation>Montoya A., Wen K., Travers J.L., Rivera-Hernandez M., White E., Mor V., Berry S.D. Resident Factors Associated with Breakthrough SARS-CoV-2 Infections. J. Am. Med. Dir. Assoc. 2023;24:901–905. doi: 10.1016/j.jamda.2023.02.102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2023.02.102</ArticleId><ArticleId IdType="pmc">PMC9977610</ArticleId><ArticleId IdType="pubmed">36965506</ArticleId></ArticleIdList></Reference><Reference><Citation>Yiu H.H.E., Yan V.K.C., Wei Y., Ye X., Huang C., Castle D.J., Chui C.S.L., Lai F.T.T., Li X., Wong C.K.H., et al. Risks of COVID-19-related hospitalisation and mortality among individuals with mental disorders following BNT162b2 and CoronaVac vaccinations: A case-control study. Psychiatry Res. 2023;329:115515. doi: 10.1016/j.psychres.2023.115515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2023.115515</ArticleId><ArticleId IdType="pubmed">37820573</ArticleId></ArticleIdList></Reference><Reference><Citation>Sass M.R., Juul T.S., Skov R., Iversen K., Harritshøj L.H., Sørensen E., Ostrowski S.R., Andersen O., Ekstrøm C.T., Ullum H., et al. SARS-CoV-2 seroprevalence among patients with severe mental illness: A cross-sectional study. PLoS ONE. 2022;17:e0264325. doi: 10.1371/journal.pone.0264325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0264325</ArticleId><ArticleId IdType="pmc">PMC8887729</ArticleId><ArticleId IdType="pubmed">35231037</ArticleId></ArticleIdList></Reference><Reference><Citation>Tregoning J.S., Flight K.E., Higham S.L., Wang Z., Pierce B.F. Progress of the COVID-19 vaccine effort: Viruses, vaccines and variants versus efficacy, effectiveness and escape. Nat. Rev. Immunol. 2021;21:626–636. doi: 10.1038/s41577-021-00592-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00592-1</ArticleId><ArticleId IdType="pmc">PMC8351583</ArticleId><ArticleId IdType="pubmed">34373623</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldfarb M., De Hert M., Detraux J., Di Palo K., Munir H., Music S., Piña I., Ringen P.A. Severe Mental Illness and Cardiovascular Disease: JACC State-of-the-Art Review. J. Am. Coll. Cardiol. 2022;80:918–933. doi: 10.1016/j.jacc.2022.06.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2022.06.017</ArticleId><ArticleId IdType="pubmed">36007991</ArticleId></ArticleIdList></Reference><Reference><Citation>Seow L.S.E., Verma S.K., Mok Y.M., Kumar S., Chang S., Satghare P., Hombali A., Vaingankar J., Chong S.A., Subramaniam M. Evaluating DSM-5 Insomnia Disorder and the Treatment of Sleep Problems in a Psychiatric Population. J. Clin. Sleep Med. 2018;14:237–244. doi: 10.5664/jcsm.6942.</Citation><ArticleIdList><ArticleId IdType="doi">10.5664/jcsm.6942</ArticleId><ArticleId IdType="pmc">PMC5786843</ArticleId><ArticleId IdType="pubmed">29394962</ArticleId></ArticleIdList></Reference><Reference><Citation>Madison A.A., Shrout M.R., Renna M.E., Kiecolt-Glaser J.K. Psychological and Behavioral Predictors of Vaccine Efficacy: Considerations for COVID-19. Perspect. Psychol. Sci. 2021;16:191–203. doi: 10.1177/1745691621989243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1745691621989243</ArticleId><ArticleId IdType="pmc">PMC7841255</ArticleId><ArticleId IdType="pubmed">33501900</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng B., Gao L., Zhou Q., Yu K., Sun F. Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: A systematic review and meta-analysis. BMC Med. 2022;20:200. doi: 10.1186/s12916-022-02397-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02397-y</ArticleId><ArticleId IdType="pmc">PMC9126103</ArticleId><ArticleId IdType="pubmed">35606843</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzur Bitan D., Kridin K., Givon-Lavi N., Krieger I., Kaliner E., Cohen A.D., Weinstein O. COVID-19 Booster Vaccination Among Individuals with Schizophrenia in Israel. JAMA Psychiatry. 2022;79:508–512. doi: 10.1001/jamapsychiatry.2022.0382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2022.0382</ArticleId><ArticleId IdType="pmc">PMC8968735</ArticleId><ArticleId IdType="pubmed">35353114</ArticleId></ArticleIdList></Reference><Reference><Citation>Fond G., Yon D.K., Boyer L. One-year results from the vaccination campaign against COVID-19 infection in 47 million individuals with severe mental disorders and other chronic diseases. Eur. Arch. Psychiatry Clin. Neurosci. 2023;273:517–521. doi: 10.1007/s00406-022-01467-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00406-022-01467-9</ArticleId><ArticleId IdType="pmc">PMC9377302</ArticleId><ArticleId IdType="pubmed">35969276</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  WHO Director-General’s Opening Remarks at the Media Briefing—5 May 2023.  [(accessed on 20 May 2023)].  Available online:  https://www.who.int/news-room/speeches/item/who-director-general-s-opening-remarks-at-the-media-briefing---5-may-2023.</Citation></Reference><Reference><Citation>Fiolet T., Kherabi Y., MacDonald C.J., Ghosn J., Peiffer-Smadja N. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: A narrative review. Clin. Microbiol. Infect. 2022;28:202–221. doi: 10.1016/j.cmi.2021.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.10.005</ArticleId><ArticleId IdType="pmc">PMC8548286</ArticleId><ArticleId IdType="pubmed">34715347</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee D.W., Bae Y.S., Lee J.R., Sohn J.H., Lee H., Lee J.Y. COVID-19 vaccination, incidence, and mortality rates among individuals with mental disorders in South Korea: A nationwide retrospective study. Asian J. Psychiatry. 2023;85:103600. doi: 10.1016/j.ajp.2023.103600.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajp.2023.103600</ArticleId><ArticleId IdType="pmc">PMC10129338</ArticleId><ArticleId IdType="pubmed">37163942</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.J., Kim M.-H., Choi M.G., Chun E.M. Psychiatric adverse events following COVID-19 vaccination: A population-based cohort study in Seoul, South Korea. Mol. Psychiatry. 2024:1–9. doi: 10.1038/s41380-024-02627-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-024-02627-0</ArticleId><ArticleId IdType="pubmed">38834668</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown J.D., Bell N. Role of psychiatric hospitals in the equitable distribution of COVID-19 vaccines. Psychiatr. Serv. 2021;72:1080–1083. doi: 10.1176/appi.ps.202000808.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ps.202000808</ArticleId><ArticleId IdType="pubmed">34015949</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>